News
-
-
PRESS RELEASE
POSITIVE CHMP OPINION SUPPORTS BROADER USE OF AMGEN'S REPATHA® BEFORE A FIRST HEART ATTACK OR STROKE
Amgen's Repatha receives positive CHMP opinion to expand use for cardiovascular disease risk reduction in high-risk adults without prior heart attack or stroke, based on VESALIUS-CV trial results -
-
-
-